Area of research
Immunology and Allergy · Physiology
Research interest
Research interests include Asthma and respiratory diseases, Allergic Rhinitis and Sensitization, Urticaria and Related Conditions, and Mast cells and histamine.
Prevention of Cardiovascular and Other Systemic Adverse Outcomes in Patients with Asthma Treated with Biologics
Adherence to Treatment in Allergic Rhinitis During the Pollen Season in Europe: A MASK‐air Study
Allergic Rhinitis and Its Impact on Asthma ( <scp>ARIA</scp> )‐ <scp>EAACI</scp> Guidelines—2024–2025 Revision: Part I—Guidelines on Intranasal Treatments
Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma ( <scp>ARIA</scp> )‐EAACI 2024–2025 Guidelines: From Evidence‐to‐Decision Frameworks to Digitalised Shared Decision‐Making Algorithms
Sex matters in <scp>CSU</scp> : Women face greater burden and poorer urticaria control, especially in midlife— <scp>CURE</scp> insights
Allergic Rhinitis and its Impact on Asthma (ARIA) Classes in MASK-air Users
Key Predictors of Adherence to a Mobile Health App for Managing Chronic Spontaneous Urticaria
Can Synthetic Data Allow for Smaller Sample Sizes in Chronic Urticaria Research?
Mucosal angioedema involving the oropharynx signals severe cold urticaria: <scp>COLD</scp> ‐ <scp>CE</scp> study insights
Poor Rhinitis and Asthma Control Is Associated With Decreased Health-Related Quality of Life and Utilities: A MASK-air Study
Non–Skin Related Symptoms Are Common in Chronic Spontaneous Urticaria and Linked to Active and Uncontrolled Disease: Results From the Chronic Urticaria Registry
Concurrent validity, cut‐offs and ability to change of patient‐reported outcome measures for rhinitis and asthma in MASK‐air<sup>®</sup>
Rhinitis associated with asthma is distinct from rhinitis alone: The <scp>ARIA‐MeDALL</scp> hypothesis
Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air<sup>®</sup>approach
Patient‐centered digital biomarkers for allergic respiratory diseases and asthma: The <scp>ARIA‐EAACI</scp> approach – ARIA‐EAACI Task Force Report
Patients With Chronic Spontaneous Urticaria Who Have Wheals, Angioedema, or Both, Differ Demographically, Clinically, and in Response to Treatment—Results From CURE
A concept for integrated care pathways for atopic dermatitis—A GA<sup>2</sup>LEN ADCARE initiative
In chronic spontaneous urticaria soluble FcεRI is elevated and linked to atopy and chronic inducible urticaria
Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK‐air<sup>®</sup> real‐world data
Comparison of rhinitis treatments using <scp>MASK</scp>‐air® data and considering the minimal important difference
Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The <scp>MASK</scp>‐air® longitudinal study
Adrenaline autoinjector is underprescribed in typical cold urticaria patients
Cutoff Values of MASK-air Patient-Reported Outcome Measures
Allergen immunotherapy in MASK‐air users in real‐life: Results of a Bayesian mixed‐effects model
Adrenaline autoinjector is under-prescribed in typical cold urticaria patients living in tropical climate countries
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
Autoimmune Diseases Are Linked to Type IIb Autoimmune Chronic Spontaneous Urticaria
Differentiation of COVID‐19 signs and symptoms from allergic rhinitis and common cold: An ARIA‐EAACI‐GA<sup>2</sup>LEN consensus
Development and validation of combined symptom‐medication scores for allergic rhinitis*
Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK‐air®